Volanesorsen is a second-generation antisense oligonucleotide designed to selectively target APOC3 messenger RNA. As a complex oligonucleotide therapeutic, product characterization should consider nucleotide sequence, backbone modifications, sugar modifications, molecular identity, purity profile, and applicable analytical specifications.
Volanesorsen is associated with selective binding to apolipoprotein C-III messenger RNA. Antisense hybridization to APOC3 mRNA is associated with mRNA degradation and reduced formation of apoC-III protein.
Apolipoprotein C-III is associated with triglyceride metabolism and the hepatic clearance of chylomicrons and other triglyceride-rich lipoproteins. APOC3 inhibition is studied in relation to plasma triglyceride pathways, chylomicron metabolism, lipoprotein metabolism, and severe hypertriglyceridemia research.
Volanesorsen is also identified in research and development literature by codes including ISIS 304801 and ISIS-APOCIIIRx. Product identity, oligonucleotide sequence, phosphorothioate backbone characteristics, 2′-O-methoxyethyl modifications, purity profile, and applicable analytical specifications should be confirmed against the approved product specification and Certificate of Analysis.
Product identity should be confirmed against the applicable Certificate of Analysis (COA) and approved product specification.
Swapnroop Drugs & Pharmaceuticals is a trusted Volanesorsen API manufacturer and supplier in India, supplying quality-focused pharmaceutical materials for antisense oligonucleotide research, APOC3 inhibitor research, lipid metabolism pharmaceutical development, triglyceride pathway research, oligonucleotide analytical development, and global pharmaceutical requirements.
Our Volanesorsen API is supplied with a strong commitment to quality, regulatory compliance, product consistency, comprehensive documentation, and dependable worldwide distribution.
We support customer-specific specifications while meeting applicable pharmaceutical quality, oligonucleotide analytical, and documentation requirements.
Volanesorsen is an antisense oligonucleotide active pharmaceutical ingredient associated with APOC3 mRNA targeting, apolipoprotein C-III synthesis inhibition, triglyceride metabolism, chylomicron pathways, triglyceride-rich lipoprotein research, and lipid-modifying pharmaceutical development.
It is commonly associated with pharmaceutical research and development involving APOC3 messenger RNA, apolipoprotein C-III, antisense hybridization, RNase H1-mediated RNA degradation pathways, triglyceride metabolism, familial chylomicronemia research, and antisense oligonucleotide drug development.
Volanesorsen research
Volanesorsen API research
ISIS 304801 research
ISIS-APOCIIIRx research
Antisense oligonucleotide research
ASO research
Antisense therapeutic research
Therapeutic oligonucleotide research
Modified oligonucleotide research
Second-generation antisense oligonucleotide research
2′-O-Methoxyethyl oligonucleotide research
2′-MOE antisense research
Phosphorothioate oligonucleotide research
APOC3 research
APOC3 mRNA research
APOC3 antisense research
APOC3 inhibitor research
APOC3 gene expression research
Apolipoprotein C-III research
ApoC-III research
ApoC-III inhibitor research
Apolipoprotein synthesis inhibition research
Messenger RNA targeting research
mRNA targeting research
Antisense hybridization research
RNA degradation research
RNase H1 pathway research
Gene expression modulation research
Gene silencing research
RNA therapeutics research
Nucleic acid therapeutics research
Triglyceride metabolism research
Triglyceride research
Plasma triglyceride research
Hypertriglyceridemia research
Severe hypertriglyceridemia research
Lipid metabolism research
Lipid pharmacology research
Lipoprotein metabolism research
Triglyceride-rich lipoprotein research
Chylomicron research
Chylomicron metabolism research
Chylomicron clearance research
Familial chylomicronemia research
Familial chylomicronemia syndrome research
FCS research
Rare lipid disorder research
Dyslipidemia research
Metabolic disease research
Cardiometabolic research
Apolipoprotein research
Lipoprotein lipase pathway research
LPL pathway research
Lipid-modifying pharmaceutical research
APOC3 inhibitor drug development
Antisense oligonucleotide drug development
Oligonucleotide pharmaceutical development
RNA-targeting drug development
Metabolic drug development
Lipid-lowering pharmaceutical research
Pharmaceutical formulation development
Injectable formulation development
Active pharmaceutical ingredient development
Oligonucleotide analytical research
Pharmaceutical analytical research
Quality control laboratories
Analytical method development
Oligonucleotide purity analysis
Sequence identity analysis
Impurity profiling studies
Stability studies
Reference standard applications
Pharmaceutical R&D
Oligonucleotide R&D
Contract manufacturing support
Research and development applications
Trusted API & Pharmaceutical Raw Material Supplier
Quality-Focused Pharmaceutical Materials
COA & Technical Documentation Support
Customer-Specific Specifications
Reliable Global Supply Chain
Competitive Commercial Pricing
Specialized Oligonucleotide Material Supply Support
Customized Packaging Solutions
Export Documentation Assistance
Professional Technical Support
Timely Worldwide Delivery
Swapnroop Drugs & Pharmaceuticals supplies Volanesorsen API to:
Pharmaceutical Manufacturers
Oligonucleotide Pharmaceutical Companies
Antisense Oligonucleotide Drug Developers
RNA Therapeutics Companies
Nucleic Acid Therapeutics Companies
APOC3 Inhibitor Drug Developers
Lipid-Modifying Pharmaceutical Companies
Metabolic Pharmaceutical Companies
Hypertriglyceridemia Research Organizations
Familial Chylomicronemia Research Organizations
FCS Research Organizations
APOC3 Research Organizations
Apolipoprotein Research Organizations
Triglyceride Research Organizations
Lipid Metabolism Research Organizations
Lipoprotein Research Organizations
Chylomicron Research Organizations
RNA Biology Research Organizations
Gene Expression Research Organizations
Antisense Technology Research Organizations
Oligonucleotide Research Organizations
Pharmaceutical Development Companies
Biotechnology Companies
Biopharmaceutical Companies
Research Organizations
Contract Research Organizations (CROs)
Contract Development & Manufacturing Organizations (CDMOs)
Oligonucleotide CDMOs
Pharmaceutical R&D Centers
Biopharmaceutical R&D Centers
Universities & Research Institutes
Analytical Laboratories
International Pharmaceutical Buyers
Located in Chhatrapati Sambhajinagar (Aurangabad), Maharashtra, India, we support domestic and international pharmaceutical supply requirements with efficient logistics and export documentation assistance.
We support Volanesorsen API enquiries from pharmaceutical companies, oligonucleotide pharmaceutical organizations, antisense drug developers, RNA therapeutics companies, APOC3 inhibitor research organizations, lipid metabolism pharmaceutical companies, biotechnology companies, research institutes, analytical laboratories, and international pharmaceutical buyers across India and global markets.
Our team assists customers with:
Product Specifications
Certificate of Analysis (COA)
Technical Documentation
Oligonucleotide Analytical Documentation
Packaging Options
Commercial Quotations
Export Documentation
Worldwide Shipping Support
Supply enquiries are subject to product availability, customer verification, intended end-use, intellectual property considerations, applicable pharmaceutical regulations, oligonucleotide manufacturing requirements, destination-country requirements, and regulatory requirements.
Get Bulk Quote via WhatsApp